PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 147 filers reported holding PLIANT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2 | -33.3% | 196 | 0.0% | 0.00% | – |
| Q1 2024 | $3 | -25.0% | 196 | 0.0% | 0.00% | – |
| Q4 2023 | $4 | +33.3% | 196 | 0.0% | 0.00% | – |
| Q3 2023 | $3 | -25.0% | 196 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | -20.0% | 196 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | +25.0% | 196 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 196 | +59.3% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 123 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 123 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 123 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 123 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 123 | +83.6% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 67 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | +50.0% | 67 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | – | 67 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $40,933,000 | 11.11% |
| CHI Advisors LLC | 2,657,457 | $18,629,000 | 7.92% |
| TRV GP IV, LLC | 2,132,867 | $14,951,000 | 5.48% |
| Redmile Group, LLC | 3,080,801 | $21,596,000 | 0.67% |
| Bond & Devick Financial Network, Inc. | 120,160 | $842,000 | 0.67% |
| Fernwood Investment Management, LLC | 186,110 | $1,758,000 | 0.62% |
| HARVARD MANAGEMENT CO INC | 562,379 | $3,942,000 | 0.40% |
| Cormorant Asset Management, LP | 482,413 | $3,382,000 | 0.26% |
| First Light Asset Management, LLC | 411,328 | $2,883,000 | 0.25% |
| Soleus Capital Management, L.P. | 240,000 | $1,682,000 | 0.22% |